VEERHEALTHPharmaceuticals
Veerhealth Care Ltd — Profit & Loss Statement
₹20.14
+0.15%
Veerhealth Care Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | -4800.00 | -8100.00 | 0.00 | — |
| Tax Rate For Calcs | 0.23 | 0.30 | 0.30 | 0.30 | — |
| Normalized EBITDA | 1.68 Cr | 2.00 Cr | 1.74 Cr | 0.81 Cr | — |
| Total Unusual Items | 0.00 | -16000.00 | -27000.00 | 0.00 | — |
| Total Unusual Items Excluding Goodwill | 0.00 | -16000.00 | -27000.00 | 0.00 | — |
| Net Income From Continuing Operation Net Minority Interest | 0.39 Cr | 0.41 Cr | 1.58 Cr | -0.07 Cr | — |
| Reconciled Depreciation | 0.91 Cr | 0.71 Cr | 0.62 Cr | 0.52 Cr | — |
| Reconciled Cost Of Revenue | 11.40 Cr | 9.13 Cr | 9.23 Cr | 6.92 Cr | — |
| EBITDA | 1.68 Cr | 2.00 Cr | 1.74 Cr | 0.81 Cr | — |
| EBIT | 0.77 Cr | 1.29 Cr | 1.12 Cr | 0.28 Cr | — |
| Net Interest Income | -0.26 Cr | -76000.00 | -64000.00 | 0.15 Cr | — |
| Interest Expense | 0.26 Cr | 76000.00 | 0.00 | 0.04 Cr | — |
| Normalized Income | 0.39 Cr | 0.41 Cr | 1.58 Cr | -0.07 Cr | — |
| Net Income From Continuing And Discontinued Operation | 0.39 Cr | 0.41 Cr | 1.58 Cr | -0.07 Cr | — |
| Total Expenses | 17.12 Cr | 13.32 Cr | 13.04 Cr | 10.64 Cr | — |
| Diluted NI Availto Com Stockholders | 0.39 Cr | 0.41 Cr | 1.58 Cr | -0.07 Cr | — |
| Net Income Common Stockholders | 0.39 Cr | 0.41 Cr | 1.58 Cr | -0.07 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 0.39 Cr | 0.41 Cr | 1.58 Cr | -0.07 Cr | — |
| Net Income Including Noncontrolling Interests | 0.39 Cr | 0.41 Cr | 1.58 Cr | -0.07 Cr | — |
| Net Income Continuous Operations | 0.39 Cr | 0.41 Cr | 1.58 Cr | -0.07 Cr | — |
| Tax Provision | 0.12 Cr | 0.88 Cr | -0.47 Cr | 0.31 Cr | — |
| Pretax Income | 0.51 Cr | 1.28 Cr | 1.12 Cr | 0.24 Cr | — |
| Other Non Operating Income Expenses | 1.22 Cr | 1.39 Cr | 0.94 Cr | 1.17 Cr | — |
| Special Income Charges | 0.00 | -16000.00 | -27000.00 | 0.00 | — |
| Net Non Operating Interest Income Expense | -0.26 Cr | -76000.00 | -64000.00 | 0.15 Cr | — |
| Interest Expense Non Operating | 0.26 Cr | 76000.00 | 0.00 | 0.04 Cr | — |
| Operating Income | -0.45 Cr | -0.10 Cr | 0.18 Cr | -1.09 Cr | — |
| Operating Expense | 5.72 Cr | 4.19 Cr | 3.81 Cr | 3.71 Cr | — |
| Other Operating Expenses | 3.23 Cr | 2.17 Cr | 0.79 Cr | 0.82 Cr | — |
| Depreciation And Amortization In Income Statement | 0.91 Cr | 0.71 Cr | 0.62 Cr | 0.52 Cr | — |
| Depreciation Income Statement | 0.91 Cr | 0.71 Cr | 0.62 Cr | 0.52 Cr | — |
| Gross Profit | 5.27 Cr | 4.09 Cr | 4.00 Cr | 2.63 Cr | — |
| Cost Of Revenue | 11.40 Cr | 9.13 Cr | 9.23 Cr | 6.92 Cr | — |
| Total Revenue | 16.67 Cr | 13.22 Cr | 13.23 Cr | 9.55 Cr | — |
| Operating Revenue | 16.67 Cr | 13.22 Cr | 13.23 Cr | 9.55 Cr | — |
| Write Off | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Income | — | 0.40 Cr | 0.30 Cr | 0.49 Cr | 0.41 Cr |
| Rent Expense Supplemental | — | 0.00 | 0.02 Cr | 96000.00 | 40000.00 |
| Diluted Average Shares | — | 1.93 Cr | 2.00 Cr | 1.39 Cr | 1.39 Cr |
| Basic Average Shares | — | 1.93 Cr | 2.00 Cr | 1.39 Cr | 1.39 Cr |
| Diluted EPS | — | 0.21 | 0.76 | -0.06 | 0.28 |
| Basic EPS | — | 0.21 | 0.76 | -0.06 | 0.28 |
| Other Special Charges | — | 16000.00 | 27000.00 | — | — |
| Total Other Finance Cost | — | 0.33 Cr | 0.31 Cr | 0.30 Cr | 79000.00 |
| Interest Income Non Operating | — | 0.40 Cr | 0.30 Cr | 0.49 Cr | 0.41 Cr |
| Selling General And Administration | — | 1.11 Cr | 1.45 Cr | 1.20 Cr | 0.78 Cr |
| Selling And Marketing Expense | — | 0.71 Cr | 1.10 Cr | 0.90 Cr | 0.59 Cr |
| General And Administrative Expense | — | 0.41 Cr | 0.35 Cr | 0.30 Cr | 0.19 Cr |
| Rent And Landing Fees | — | 0.00 | 0.02 Cr | 96000.00 | 40000.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Veerhealth Care Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.